A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, U.S., ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
allAfrica.com on MSN
Zimbabwe: Govt to Roll Out Twice-Yearly HIV Injection in Major Prevention Push
Zimbabwe is preparing to place at least 46 500 people on a long-acting HIV prevention drug early next year marking the country's first rollout of Lenacapavir a twice-yearly injectable that offers ...
HIV Virus Creative artwork featuring colorized 3D prints of HIV virus particles. The virus surface (red) is covered with proteins (dark blue) that enable the virus to enter and infect human cells, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback